Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

More research needed to confirm finasteride as standard treatment for FFA.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

5ARI treatment improves hair growth in older men with minimal side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Targeting FGF5 could help treat prostate cancer.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.